Mutation Detection Kits In Genome Editing Market Report 2026

Mutation Detection Kits In Genome Editing Market Overview

• Mutation Detection Kits In Genome Editing market size has reached to $1.14 billion in 2025 • Expected to grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 13% • Growth Driver: Rising Prevalence Of Genetic Disorders Fueling The Market Growth Due To Increasing Need For Accurate Mutation Identification • Market Trend: Advancements In Ultrasensitive Multiplexed Assays Enhance Genetic Mutation Detection • North America was the largest region in 2025 and Asia‑Pacific is the fastest growing region.

What Is Covered Under Mutation Detection Kits In Genome Editing Market?

Mutation detection kits for genome editing are specialized tools used to identify and analyze genetic changes introduced during the editing process. They enable accurate detection of insertions, deletions, and substitutions in deoxyribonucleic acid (DNA) sequences, ensuring precise validation of editing results. They provide valuable data for optimizing genome editing techniques and improving overall experimental efficiency. The main product types of mutation detection kits in genome editing are reagents, kits, and software solutions. Reagents are specialized chemicals or mixtures that drive and support precise biochemical reactions in genetic testing, directly impacting accuracy and efficiency. It utilizes various technologies such as clustered regularly interspaced short palindromic repeats (CRISPR), transcription activator-like effector nucleases or meganuclease-TAL effector nucleases (TALENs/MegaTALs), zinc finger nucleases (ZFNs), and other technologies. These are used in several applications, including research, clinical diagnostics, drug development, and other applications, and also by several end-users such as academic institutions, hospitals and diagnostic centers, and biotechnology companies.

What Is The Mutation Detection Kits In Genome Editing Market Growth Forecast?

The mutation detection kits in genome editing market size is expected to see rapid growth in the next few years. It will grow to $2.1 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to development of advanced crispr-based mutation validation kits, rising investment in next-generation sequencing technologies, expansion of cloud-based bioinformatics solutions, increasing applications in clinical diagnostics and personalized medicine, integration of ai-driven data interpretation tools. Major trends in the forecast period include rising adoption of pcr-based and next-generation sequencing mutation detection kits, increasing use of crispr mutation validation tools in genome editing research, growth in software solutions for genomic data analysis and visualization, expansion of mutation detection applications in drug development and clinical diagnostics, integration of cloud-based bioinformatics platforms for real-time data interpretation.

Global Mutation Detection Kits In Genome Editing Market Segmentation

1) By Product Type: Reagents, Kits, Software Solutions 2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies 3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications 4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies Subsegments: 1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides 2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits 3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms

What Is The Driver Of The Mutation Detection Kits In Genome Editing Market?

The rising prevalence of genetic disorders is expected to propel the growth of the mutation detection kits in the genome editing market going forward. Genetic disorders refer to diseases or conditions caused by abnormalities in an individual's DNA, which may be inherited from parents or occur due to new genetic mutations. The rise in genetic disorders is driven by greater awareness and advanced diagnostic technologies, enabling earlier and more accurate identification of conditions, resulting to higher reported prevalence rates. Genome editing mutation detection kits help address genetic disorders by accurately identifying disease-causing gene mutations, enabling targeted research and the development of precise therapeutic interventions. For instance, in May 2024, according to the National Health Service, a UK-based government department, in England, approximately 17,000 people live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Therefore, the rising prevalence of genetic disorders is driving the growth of the mutation detection kits in the genome editing market.

Key Players In The Global Mutation Detection Kits In Genome Editing Market

Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, BioVision Inc., Creative Biogene Corporation

Global Mutation Detection Kits In Genome Editing Market Trends and Insights

Major companies operating in the mutation detection kits in the genome editing market are focusing on developing advanced products such as ultrasensitive multiplexed assays to enhance accuracy, speed, and sensitivity in detecting genetic mutations. Ultrasensitive multiplexed assays are advanced diagnostic tests that can detect and measure multiple genetic mutations simultaneously at very low levels, helping researchers and clinicians achieve faster, more accurate, and more comprehensive mutation analysis for better disease diagnosis and treatment monitoring. For instance, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay designed for breast cancer mutation detection. This kit enables simultaneous identification and precise quantification of seven ESR1 mutations with an analytical sensitivity down to 0.01% variant allele fraction, supporting both plasma and tissue sample analysis. Such innovations exemplify the industry’s commitment to improving diagnostic accuracy and enabling more effective disease monitoring and personalized treatment strategies.

What Are Latest Mergers And Acquisitions In The Mutation Detection Kits In Genome Editing Market?

In March 2025, ERS Genomics Limited, an Ireland-based biotechnology company, partnered with Jumpcode Genomics Inc. to enhance next-generation sequencing capabilities. With this partnership, Jumpcode Genomics Inc. aims to leverage ERS Genomics Limited’s CRISPR/Cas9 patent portfolio to advance its next-generation sequencing technologies, enabling higher sensitivity, improved efficiency, and expanded applications in areas such as basic research, infectious disease detection, molecular diagnostics, and oncology. Jumpcode Genomics Inc. is a US-based life science tools company that offers advanced tools for mutation detection and genome editing.

Regional Insights

North America was the largest region in the mutation detection kits in genome editing market in 2025. Asia‑Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Mutation Detection Kits In Genome Editing Market?

The mutation detection kits genome editing market consists of revenues earned by entities by providing services such as the development of specialized assays, manufacturing and distribution of mutation detection kits, CRISPR validation and off-target analysis services, next-generation sequencing (NGS)-based mutation identification, and supplying bioinformatics tools for interpreting genetic modification data. The market value includes the value of related goods sold by the service provider or included within the service offering. The mutation detection kits genome editing market also includes sales of Sanger sequencing-based mutation detection kits, fluorescent reporter-based detection systems, high-resolution melt analysis (HRMA) kits, and droplet digital PCR (ddPCR) mutation detection kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Mutation Detection Kits In Genome Editing Market Report 2026?

The mutation detection kits in genome editing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the mutation detection kits in genome editing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.